Abstract: Investigation of the culture of basidiomycete Polyporus ellisii led to the isolation of a novel compound 3β,9α,15α-trihydroxy-(22E,24R)-10(5→4)-abeo-ergosta-6,8(14),22-trien-5-one (1) with a new 5/7/6/5 ring system of ergosterol skeleton. In addition, five new steroids, 5β,6β-epoxy-3β,7α,9α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one (2), 5β,6β-epoxy-3β,7α-dihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one (3), 5α,6α-epoxy-3β,9α,15α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-7-one (4), 15α-acetoxy-(22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one (5), 15β-methoxy-(22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one (6), along with four known ergosterols (7-10), were obtained. All structures were elucidated based on 1D and 2D NMR spectral data. New compounds were evaluated for cytotoxicity against five human cancer cell lines, only compound 4 was found to exhibit a favorable cytotoxicity profile toward all tested tumor cell lines.
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Introduction
The fungus Polyporus ellisii, belonging to the family Polyporaceae, is widely distributed in Yunnan and Sichuan Provinces of China. We had previously isolated biologically active cerebrosides from the fruiting bodies of P. ellisii. [1] [2] [3] In this study, a novel compound 3β,9α,15α-trihydroxy-(22E,24R)-10(5→4)-abeo-ergosta-6,8(14),22-trien-5-one (1) with a new 5/7/6/5 ring system was obtained from the culture of P. ellisii. In addition, three new multioxygenbearing ergosterols, namely 5β,6β-epoxy-3β,7α,9α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one (2), 5β,6β-epoxy-3β,7α-dihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one (3), 5α,6α-epoxy-3β,9α,15α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-7-one (4), and two derivatives of (22E,24R)-ergosta- 4,6,8(14) ,22-tetraen-3-one, namely 15α-acetoxy-(22E, 24R)-ergosta- 4,6,8(14) ,22-tetraen-3-one (5), 15β-methoxy-(22 E,24R)-ergosta- 4,6,8(14) ,22-tetraen-3-one (6), were obtained. Four known ergosterols, 3β,15α-dihydroxy-(22E,24R)-ergosta-5,8(14),22-trien-7-one (7) 4 , 3β,15β-dihydroxy-(22E,24R)-ergosta-5,8(14),22-trien-7-one (8) 4 , (22E,24R)-ergosta-6,9,22-trien-3β,5α,8α-triol (9) 5 , (22E,24R)-ergosta- 4,6,8(14) ,22-tetraen-3,15-dione (gymnasterone, 10) 6 were also isolated from the species. New compounds were evaluated for cytotoxicity against five human cancer cell lines. Compound 1 showed cytotoxic activity against four cell lines, and compound 4 exhibited a favorable cytotoxicity profile toward all tested tumor cell lines.
Results and Discussion
Compound 1, obtained as a light yellow amorphous powder, had a molecular formula of C 28 H 42 O 4 on the basis of the positive HRESIMS, which showed a molecular ion peak at m/z 465.2980 (calcd for C 28 H 42 O 4 Na), and accounted for 8 degrees of unsaturation. The presence of a conjugated system was confirmed by UV spectrum which showed maximum absorption at 292 nm. The IR spectrum indicated the presence 4 and confirmed by HMBC and COSY correlations. Compared to the other ergosterols isolated from the same fungus, the differences were the presence of changed rings A and B. The unsaturated ketone carbonyl carbon at δ C 203.8 was located at C-5, confirmed by HMBC correlations between H-7, H-4, H-3/C-5. The olefinic group at δ C 123.5, 145.9 (δ H 5.89 d, 7.52 d) was attributed to C-6 and C-7. Since the two olefinic protons coupled each other in 1 H-1 H COSY spectrum and there existed HMBC correlations from H-6 to C-4, C-7, C-8 and from H-7 to C-5, C-6, C-8, C-9. The HMBC correlations mentioned above implied the existence of an unusual seven-membered ring B. A combination of COSY and HSQC showed the connectivities C-4-C-3-C-2-C-1 for ring A. The existence of seven-membered ring B and five-membered ring A suggested the two rings were connected by single bond between C-4 and C-10, which was confirmed by HMBC correlations between H-4/C-18, Me-18/C-1, C-9, C-10, H-1/C-9 and H-3/C-5. Thus, the skeleton of 1 was established as an ergosterol with a rearranged 10(5→4)-abeo skeleton.
The ROESY correlations of 1 ( Figure 2 ) between H-15/Me-19 and H-4/Me-18 demonstrated that the stereochemistry of H-15 and H-4 were β-oriented, respectively. No any correlations in ROESY (in DMSO-d 6 ) between 9-OH and Me-18 or Me-19 were observed, which suggested the existence of 9α-OH. The ROESY (in DMSO-d 6 ) correlations between 9-OH and H-3 indicated the existence of 3β-OH. The stereochemistry of the side chain was established by the comparison with the known compounds (7-10) [4] [5] [6] and literature data of similar compounds 7, 8 . Thus, 1 was elucidated as 3β,9α,15α-trihydroxy-(22E,24R)-10(5→4)-abeo-ergosta-6,8(14),22-trien-5-one. 13 C NMR spectrum showed a carbonyl carbon at δ C 211.0 and five oxygen-bearing carbons at δ C 75.2, 68.0, 67.4, 62.9 and 60.9, implying the existence of an epoxy and three hydroxyl groups. The HMBC (in DMSO-d 6 ) correlations from the proton at δ H 4.72 to C-9 (δ C 74.6) and from the proton at δ H 4.81 (d) to C-3 (δ C 66.7) demonstrated the presence of hydroxyl group at C-9 and C-3, respectively. The HMBC correlations from the proton of hydroxyl group at δ H 4.16 to C-6 (δ C 60.9) and C-7 (δ C 62.9), with the signals of H-6 (δ H 3.35) and H-7 (δ H 5.39) in 1 H NMR spectrum appear as doublet (3.2) and double doublet (5.3, 3.2), respectively, suggested the presence of 5,6-epoxy. The stereochemistry of 9-OH was α-oriented due to the skeleton of B/C trans.
9, 10 The ROESY correlations (in DMSO-d 6 ) between H-7 (δ H 5.50)/Me-18 (δ H 0.87), 7-OH (δ H 4.92)/9-OH (δ H 4.72), 7-OH (δ H 4.92)/H-6 (δ H 3.24) and between H-6 (δ H 3.24)/ H-4α (δ H 1.18), suggested the presence of 7α-OH and 5β,6β-epoxy. The stereochemistry of H-3 was determined to be α-oriented due to its downfield shifted broad multiplet at δ H 3.96 (W 1/2 = 20.0 Hz) 10, 11 . The stereochemistry of the side chain of 2 was established by the comparison with the known compounds (7-10) [4] [5] [6] and literature data of similar compounds. 7, 8 Thus, 2 was assigned as 5β,6β-epoxy-3β,7α,9α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one.
The NMR data of compounds 3 and 4 were similar to those of 2. The only difference between 3 and 2 appears to be the group at C-9. The hydroxyl at C-9 of 2 was replaced by a proton in compound 3, which was confirmed by HMBC correlations from H-9 to C-10, C-11, C-14, and C-8. The ROESY correlations between H-7 (δ H 5.13)/Me-18 (δ H 0.92) and H-6 (δ H 3.17)/H-9 (δ H 2.79) demonstrated the existence of 7α-OH and 5β,6β-epoxy. Thus, the structure of 3 was identified as 5β,6β-epoxy-3β,7α-dihydroxy-(22E,24R)-ergosta-8(14),22-dien-15-one.
The differences between 4 and 2 appears to be the groups at C-7 and C-15 and the stereochemistry of 5,6-epoxy. The HMBC correlations of 4 from H-6 (δ H 3.37) to C-7 (δ C 196.7) and from H-15 (δ H 4.92) to C-13 (δ C 47.8), C-16 (δ C 36.5) and C-17 (δ C 53.0), proved that the groups at C-7 and C-15 were carbonyl and hydroxyl, respectively. The ROESY correlations between H-15 (δ H 4.92)/Me-19 (δ H 0.93), H-6 (δ H 3.37)/Me-18 (δ H 1.08), H-6 (δ H 3.37)/H-4β (δ H 2.29) and Me-18 (δ H 1.08)/H-4β (δ H 2.29), demonstrated the existence of 15α-OH and 5α,6α-epoxy. Thus, 4 was characterized as 5α,6α-epoxy-3β,9α,15α-trihydroxy-(22E,24R)-ergosta-8(14),22-dien-7-one.
Compound 5 was obtained as a light yellow amorphous powder. The molecular formula was established to be C 30 H 42 O 3 on the basis of the positive HRESIMS at m/z 451.3212 (calcd for C 30 H 42 O 3 H, 451.3221). The UV spectrum showed the maximum absorption at 333 nm, indicating the existence of a long conjugation system. As shown in Tables 1  and 2 , the NMR data showed six characteristic ergosterol methyls. Actually, the data were similar to those of (22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one, 12 with the only difference at the group of C-15. The HMBC correlations from H-15 (δ H 5.78) to C-1' (δ C 170.6) and from Me-2' (δ H 2.03) to C-1' (δ C 170.6) demonstrated the existence of acetoxy group at C-15 in 5. The ROESY correlations between H-15 (δ H 5.78)/Me-19 (δ H 1.10) indicated the acetoxy group at C-15 was α-oriented. Based on the above evidence, 5 was elucidated as 15α-acetoxy-(22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one.
The NMR data of 6 were similar with those of 5, expect that acetoxy group at C-15 in 5 was replaced by methoxy group. The ROESY correlations between H-15 (δ H 4.33)/H-17 (δ H 1.16) showed that the methoxy group at C-15 was β-oriented. Thus, 6 was deduced to be 15β-methoxy-(22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one. The isolated new sterols (1-6) were evaluated for cytotoxicity against five human tumor cell lines using MTT method (Table 3) . 4 showed significant cytotoxicity to all tested tumor cell lines.
Comparison of the physicochemical properties with the reported data allowed to identify compounds 7-10, isolated from the same fungus, as 3β,15α-dihydroxy-(22E,24R)-ergosta-5,8(14),22-trien-7-one (7) 4 , 3β,15β-dihydroxy-(22E,24 R)-ergosta -5,8(14) ,22-trien-7-one (8) 4 , (22E,24R)-ergosta-6,9, 22-trien-3β,5α,8α-triol (9) 5 , (22E,24R)-ergosta-4,6,8(14),22-tetraen-3,15-dione (gymnasterone, 10) 6 , respectively.
Experimental Section
General Experimental Procedures. Optical rotations were measured on a Jasco-P-1020 polarimeter. IR spectra were obtained by using a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. NMR spectra were acquired with instruments of Avance Ш 600, Bruker DRX-500 or Bruker AV 400. ESIMS and HSESIMS were measured on Bruker HCT/Esquire and API QSTAR Pulsar, respectively. Silica gel (200300 mesh and 80100 mesh, Qingdao Marine Chemical Inc., China) and Sephadex LH-20 (Amersham Biosciences, Sweden) were used for column chromatography. Fractions were monitored by TLC and spots were visualized by heating silica gel plates immersed in vanillin-H 2 SO 4 in EtOH, in combination with Agilent 1200 series HPLC system (Eclipse XDB-C18 column, 5 μm, 4.6 × 150 mm). Preparative HPLC was performed on an Agilent 1100 series with a Zorbax SB-C18 (5 mm, 9.4 × 150 mm) column. Preparative MPLC was performed on Büchi apparatus equipped with Büchi fraction collector C-660, Büchi pump module C-605 and manager C-615. 1 H NMR data (see Table 1 ); 13 C NMR data (see Table 2 1 H NMR data (see Table 1 ); 13 C NMR data (see Table 2 Table 1 ); 13 C NMR data (see Table 2 Table 1 ); 13 C NMR data (see Table 2 -(22E,24R)-ergosta-4,6,8(14),22-tetraen-3 1 H NMR data (see Table 1 );
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C NMR data (see Table 2 
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